Dr. Philip Henry Kohler, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1801 Hickman Rd, Des Moines, IA 50314 Phone: 515-282-2200 |
Dr. Kevin Krishna Birusingh, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1350 Des Moines St Ste 100, Des Moines, IA 50309 Phone: 515-643-0400 Fax: 515-643-0401 |
Dr. Ryan Schulte, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1350 Des Moines St Ste 100, Des Moines, IA 50309 Phone: 515-643-0400 Fax: 515-643-0401 |
Dr. Richard L Glowacki, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1350 Des Moines St Ste 100, Des Moines, IA 50309 Phone: 515-643-0400 Fax: 515-643-0401 |
Dr. Leland Merrill Coffman, D.O. Urology Medicare: Not Enrolled in Medicare Practice Location: 3600 30th St, Des Moines, IA 50310 Phone: 515-699-5907 |
Dr. Mark Alvin Kellerman, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1350 Des Moines St Ste 100, Des Moines, IA 50309 Phone: 515-643-0400 Fax: 515-643-0401 |
News Archive
According the Centers for Disease Control and Prevention, approximately 6 - 8% of pregnant women experience hypertension. High blood pressure during pregnancy is associated with a number of risks to the woman and fetus, including low-birth weight infants, preterm birth, problems with the placenta, heavy bleeding, heart defects and other congenital anomalies, and in the most severe cases death.
Multicomponent reactions are protocols that ease the chemical synthesis of new compounds, and are particularly important to gain molecules with biological activity as therapeutic agents against several pathogens.
The Alzheimer's Foundation of America issued this statement today regarding passage of the National Alzheimer's Project Act. The National Alzheimer's Project Act would create the National Alzheimer's Project, which would coordinate government efforts to prevent and treat the disease and create a national strategy for defeating Alzheimer's disease.
Celsion Corporation, a leading oncology drug development company, announced that the Company has reached agreement with the U.S. Food and Drug Administration (FDA) that the requirements for non-clinical studies have been met for the New Drug Application (NDA) of ThermoDox.
› Verified 4 days ago